Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Clinical trial NCT05239832 · UNKNOWN
Trial details
- NCT number
- NCT05239832
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2021-09-29
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.